Immunohistochemistry revealed that SETD2 was localized in the cell nucleus of normal renal tubular epithelial cells, and was strikingly decreased in ccRCC tissues (Figure 1E). The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.